Zhang et al. [28] selected eligible CRC patients from the SEER database and created a nomogram containing CEA expressions and other clinic-pathological factors, which showed accuracy and risk assessment ability than the AJCC staging system. This evidence concerns the gene CEACAM5 and colorectal carcinoma.